<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28765561</PMID><DateCompleted><Year>2019</Year><Month>02</Month><Day>11</Day></DateCompleted><DateRevised><Year>2019</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Antibodies Against Modified NS1 Wing Domain Peptide Protect Against Dengue Virus Infection.</ArticleTitle><Pagination><StartPage>6975</StartPage><MedlinePgn>6975</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">6975</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-017-07308-3</ELocationID><Abstract><AbstractText>Dengue is the most common mosquito-transmitted viral infection for which an improved vaccine is still needed. Although nonstructural protein-1 (NS1) immunization can protect mice against dengue infection, molecular mimicry between NS1 and host proteins makes NS1-based vaccines challenging to develop. Based on the epitope recognized by the anti-NS1 monoclonal Ab (mAb) 33D2 which recognizes a conserved NS1 wing domain (NS1-WD) region but not host proteins, we synthesized a modified NS1-WD peptide to immunize mice. We found that both mAb 33D2 and modified NS1-WD peptide immune sera could induce complement-dependent lysis of dengue-infected but not un-infected cells in vitro. Furthermore, either active immunization with the modified NS1-WD peptide or passive transfer of mAb 33D2 efficiently protected mice against all serotypes of dengue virus infection. More importantly, dengue patients with more antibodies recognized the modified NS1-WD peptide had less severe disease. Thus, the modified NS1-WD peptide is a promising dengue vaccine candidate.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Yen-Chung</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>The Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chuang</LastName><ForeName>Yung-Chun</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ching-Chuan</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Tzong-Shiann</ForeName><Initials>TS</Initials><Identifier Source="ORCID">0000-0003-2951-6679</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yee-Shin</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Departments of Microbiology &amp; Immunology and Pediatrics, and Canadian Center for Vaccinology, Dalhousie University, Halifax, Nova Scotia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeh</LastName><ForeName>Trai-Ming</ForeName><Initials>TM</Initials><Identifier Source="ORCID">0000-0003-3172-7432</Identifier><AffiliationInfo><Affiliation>Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, Taiwan. today@mail.ncku.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>08</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053059">Dengue Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003429" MajorTopicYN="N">Cross Reactions</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053059" MajorTopicYN="N">Dengue Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061307" MajorTopicYN="N">Human Umbilical Vein Endothelial Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072417" MajorTopicYN="N">Protein Domains</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065288" MajorTopicYN="N">Serogroup</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017361" MajorTopicYN="N">Viral Nonstructural Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28765561</ArticleId><ArticleId IdType="pmc">PMC5539099</ArticleId><ArticleId IdType="doi">10.1038/s41598-017-07308-3</ArticleId><ArticleId IdType="pii">10.1038/s41598-017-07308-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bhatt S, et al. The global distribution and burden of dengue. Nature. 2013;496:504&#x2013;507. doi: 10.1038/nature12060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12060</ArticleId><ArticleId IdType="pmc">PMC3651993</ArticleId><ArticleId IdType="pubmed">23563266</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman MG, Kouri G. Dengue haemorrhagic fever integral hypothesis: confirming observations, 1987&#x2013;2007. Trans R Soc Trop Med Hyg. 2008;102:522&#x2013;523. doi: 10.1016/j.trstmh.2008.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trstmh.2008.03.001</ArticleId><ArticleId IdType="pubmed">18420239</ArticleId></ArticleIdList></Reference><Reference><Citation>Martina BE, Koraka P, Osterhaus AD. Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev. 2009;22:564&#x2013;581. doi: 10.1128/CMR.00035-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00035-09</ArticleId><ArticleId IdType="pmc">PMC2772360</ArticleId><ArticleId IdType="pubmed">19822889</ArticleId></ArticleIdList></Reference><Reference><Citation>In Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control: New Edition WHO Guidelines Approved by the Guidelines Review Committee (2009).</Citation></Reference><Reference><Citation>Halstead SB. Identifying protective dengue vaccines: guide to mastering an empirical process. Vaccine. 2013;31:4501&#x2013;4507. doi: 10.1016/j.vaccine.2013.06.079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2013.06.079</ArticleId><ArticleId IdType="pubmed">23896423</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan SW, et al. Current progress in dengue vaccines. J Biomed Sci. 2013;20:37. doi: 10.1186/1423-0127-20-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-20-37</ArticleId><ArticleId IdType="pmc">PMC3686670</ArticleId><ArticleId IdType="pubmed">23758699</ArticleId></ArticleIdList></Reference><Reference><Citation>Vannice KS, Durbin A, Hombach J. Status of vaccine research and development of vaccines for dengue. Vaccine. 2016;34:2934&#x2013;2938. doi: 10.1016/j.vaccine.2015.12.073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.12.073</ArticleId><ArticleId IdType="pubmed">26973072</ArticleId></ArticleIdList></Reference><Reference><Citation>Guy B, Lang J, Saville M, Jackson N. Vaccination Against Dengue: Challenges and Current Developments. Annu Rev Med. 2016;67:387&#x2013;404. doi: 10.1146/annurev-med-091014-090848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-091014-090848</ArticleId><ArticleId IdType="pubmed">26515983</ArticleId></ArticleIdList></Reference><Reference><Citation>Henchal EA, Putnak JR. The dengue viruses. Clin Microbiol Rev. 1990;3:376&#x2013;396. doi: 10.1128/CMR.3.4.376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.3.4.376</ArticleId><ArticleId IdType="pmc">PMC358169</ArticleId><ArticleId IdType="pubmed">2224837</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler G, Maxwell SE, Ruemmler C, Stollar V. Newly synthesized dengue-2 virus nonstructural protein NS1 is a soluble protein but becomes partially hydrophobic and membrane-associated after dimerization. Virology. 1989;171:302&#x2013;305. doi: 10.1016/0042-6822(89)90544-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(89)90544-8</ArticleId><ArticleId IdType="pubmed">2525840</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlesinger JJ, Brandriss MW, Putnak JR, Walsh EE. Cell surface expression of yellow fever virus non-structural glycoprotein NS1: consequences of interaction with antibody. J Gen Virol. 1990;71(Pt 3):593&#x2013;599. doi: 10.1099/0022-1317-71-3-593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-71-3-593</ArticleId><ArticleId IdType="pubmed">2138210</ArticleId></ArticleIdList></Reference><Reference><Citation>Crooks AJ, Lee JM, Dowsett AB, Stephenson JR. Purification and analysis of infectious virions and native non-structural antigens from cells infected with tick-borne encephalitis virus. J Chromatogr. 1990;502:59&#x2013;68. doi: 10.1016/S0021-9673(01)89563-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9673(01)89563-7</ArticleId><ArticleId IdType="pubmed">2157727</ArticleId></ArticleIdList></Reference><Reference><Citation>Crooks AJ, Lee JM, Easterbrook LM, Timofeev AV, Stephenson JR. The NS1 protein of tick-borne encephalitis virus forms multimeric species upon secretion from the host cell. J Gen Virol. 1994;75(Pt 12):3453&#x2013;3460. doi: 10.1099/0022-1317-75-12-3453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-75-12-3453</ArticleId><ArticleId IdType="pubmed">7527836</ArticleId></ArticleIdList></Reference><Reference><Citation>Akey DL, et al. Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system. Science. 2014;343:881&#x2013;885. doi: 10.1126/science.1247749.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1247749</ArticleId><ArticleId IdType="pmc">PMC4263348</ArticleId><ArticleId IdType="pubmed">24505133</ArticleId></ArticleIdList></Reference><Reference><Citation>Watterson, D., Modhiran, N. &amp; Young, P. R. The many faces of the flavivirus NS1 protein offer a multitude of options for inhibitor design. Antiviral Res, doi:10.1016/j.antiviral.2016.02.014 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26944216</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutsche I, et al. Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein. Proc. Natl. Acad. Sci. USA. 2011;108:8003&#x2013;8008. doi: 10.1073/pnas.1017338108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1017338108</ArticleId><ArticleId IdType="pmc">PMC3093454</ArticleId><ArticleId IdType="pubmed">21518917</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller DA, et al. Structure of the dengue virus glycoprotein non-structural protein 1 by electron microscopy and single-particle analysis. J Gen Virol. 2012;93:771&#x2013;779. doi: 10.1099/vir.0.039321-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.039321-0</ArticleId><ArticleId IdType="pubmed">22238236</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcon S, et al. Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol. 2002;40:376&#x2013;381. doi: 10.1128/JCM.40.02.376-381.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.40.02.376-381.2002</ArticleId><ArticleId IdType="pmc">PMC153354</ArticleId><ArticleId IdType="pubmed">11825945</ArticleId></ArticleIdList></Reference><Reference><Citation>Libraty DH, et al. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis. 2002;186:1165&#x2013;1168. doi: 10.1086/343813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/343813</ArticleId><ArticleId IdType="pubmed">12355369</ArticleId></ArticleIdList></Reference><Reference><Citation>Young PR, Hilditch PA, Bletchly C, Halloran W. An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. Journal of clinical microbiology. 2000;38:1053&#x2013;1057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC86336</ArticleId><ArticleId IdType="pubmed">10698995</ArticleId></ArticleIdList></Reference><Reference><Citation>Avirutnan P, et al. Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E. PLoS Pathog. 2007;3:e183. doi: 10.1371/journal.ppat.0030183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.0030183</ArticleId><ArticleId IdType="pmc">PMC2092380</ArticleId><ArticleId IdType="pubmed">18052531</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin SW, et al. Dengue virus nonstructural protein NS1 binds to prothrombin/thrombin and inhibits prothrombin activation. J Infect. 2012;64:325&#x2013;334. doi: 10.1016/j.jinf.2011.11.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2011.11.023</ArticleId><ArticleId IdType="pubmed">22138554</ArticleId></ArticleIdList></Reference><Reference><Citation>Avirutnan P, et al. Antagonism of the complement component C4 by flavivirus nonstructural protein NS1. J Exp Med. 2010;207:793&#x2013;806. doi: 10.1084/jem.20092545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20092545</ArticleId><ArticleId IdType="pmc">PMC2856034</ArticleId><ArticleId IdType="pubmed">20308361</ArticleId></ArticleIdList></Reference><Reference><Citation>Avirutnan P, et al. Binding of flavivirus nonstructural protein NS1 to C4b binding protein modulates complement activation. Journal of immunology. 2011;187:424&#x2013;433. doi: 10.4049/jimmunol.1100750.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1100750</ArticleId><ArticleId IdType="pmc">PMC3119735</ArticleId><ArticleId IdType="pubmed">21642539</ArticleId></ArticleIdList></Reference><Reference><Citation>Beatty PR, et al. Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination. Science translational medicine. 2015;7:304ra141. doi: 10.1126/scitranslmed.aaa3787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaa3787</ArticleId><ArticleId IdType="pubmed">26355030</ArticleId></ArticleIdList></Reference><Reference><Citation>Modhiran N, et al. Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity. Science translational medicine. 2015;7:304ra142. doi: 10.1126/scitranslmed.aaa3863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaa3863</ArticleId><ArticleId IdType="pubmed">26355031</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan SW, et al. Protection against dengue virus infection in mice by administration of antibodies against modified nonstructural protein 1. PLoS One. 2014;9:e92495. doi: 10.1371/journal.pone.0092495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0092495</ArticleId><ArticleId IdType="pmc">PMC3962419</ArticleId><ArticleId IdType="pubmed">24658118</ArticleId></ArticleIdList></Reference><Reference><Citation>Henchal EA, Henchal LS, Schlesinger JJ. Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus. J Gen Virol. 1988;69(Pt 8):2101&#x2013;2107. doi: 10.1099/0022-1317-69-8-2101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-69-8-2101</ArticleId><ArticleId IdType="pubmed">3404125</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa SM, et al. DNA vaccines against dengue virus based on the ns1 gene: the influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice. Virology. 2007;358:413&#x2013;423. doi: 10.1016/j.virol.2006.08.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2006.08.052</ArticleId><ArticleId IdType="pubmed">17020777</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CL, et al. Anti-dengue virus nonstructural protein 1 antibodies cause NO-mediated endothelial cell apoptosis via ceramide-regulated glycogen synthase kinase-3beta and NF-kappaB activation. J Immunol. 2013;191:1744&#x2013;1752. doi: 10.4049/jimmunol.1201976.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1201976</ArticleId><ArticleId IdType="pubmed">23851680</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CF, et al. Generation of IgM anti-platelet autoantibody in dengue patients. Journal of medical virology. 2001;63:143&#x2013;149. doi: 10.1002/1096-9071(20000201)63:2&lt;143::AID-JMV1009&gt;3.0.CO;2-L.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1096-9071(20000201)63:2&lt;143::AID-JMV1009&gt;3.0.CO;2-L</ArticleId><ArticleId IdType="pubmed">11170051</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang YC, Lin J, Lin YS, Wang S, Yeh TM. Dengue Virus Nonstructural Protein 1-Induced Antibodies Cross-React with Human Plasminogen and Enhance Its Activation. J Immunol. 2016;196:1218&#x2013;1226. doi: 10.4049/jimmunol.1500057.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1500057</ArticleId><ArticleId IdType="pubmed">26712948</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y-S, et al. Molecular mimicry between virus and host and its implications for dengue disease pathogenesis. Experimental Biology and Medicine. 2011;236:515&#x2013;523. doi: 10.1258/ebm.2011.010339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1258/ebm.2011.010339</ArticleId><ArticleId IdType="pubmed">21502191</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu IJ, Chiu CY, Chen YC, Wu HC. Molecular mimicry of human endothelial cell antigen by autoantibodies to nonstructural protein 1 of dengue virus. J Biol Chem. 2011;286:9726&#x2013;9736. doi: 10.1074/jbc.M110.170993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.170993</ArticleId><ArticleId IdType="pmc">PMC3058979</ArticleId><ArticleId IdType="pubmed">21233208</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang YC, et al. Dengue virus-induced autoantibodies bind to plasminogen and enhance its activation. J Immunol. 2011;187:6483&#x2013;6490. doi: 10.4049/jimmunol.1102218.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1102218</ArticleId><ArticleId IdType="pubmed">22079981</ArticleId></ArticleIdList></Reference><Reference><Citation>Falconar AK. Antibody responses are generated to immunodominant ELK/KLE-type motifs on the nonstructural-1 glycoprotein during live dengue virus infections in mice and humans: implications for diagnosis, pathogenesis, and vaccine design. Clin Vaccine Immunol. 2007;14:493&#x2013;504. doi: 10.1128/CVI.00371-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CVI.00371-06</ArticleId><ArticleId IdType="pmc">PMC1865631</ArticleId><ArticleId IdType="pubmed">17329445</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HC, Hofman FM, Kung JT, Lin YD, Wu-Hsieh BA. Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage. J Virol. 2007;81:5518&#x2013;5526. doi: 10.1128/JVI.02575-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02575-06</ArticleId><ArticleId IdType="pmc">PMC1900309</ArticleId><ArticleId IdType="pubmed">17360740</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen ST, et al. CLEC5A is critical for dengue-virus-induced lethal disease. Nature. 2008;453:672&#x2013;676. doi: 10.1038/nature07013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07013</ArticleId><ArticleId IdType="pubmed">18496526</ArticleId></ArticleIdList></Reference><Reference><Citation>Zellweger RM, Shresta S. Mouse models to study dengue virus immunology and pathogenesis. Front Immunol. 2014;5:151. doi: 10.3389/fimmu.2014.00151.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00151</ArticleId><ArticleId IdType="pmc">PMC3989707</ArticleId><ArticleId IdType="pubmed">24782859</ArticleId></ArticleIdList></Reference><Reference><Citation>Shresta S, et al. Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice. J Immunol. 2005;175:3946&#x2013;3954. doi: 10.4049/jimmunol.175.6.3946.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.175.6.3946</ArticleId><ArticleId IdType="pubmed">16148142</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB, Venkateshan CN, Gentry MK, Larsen LK. Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies. J Immunol. 1984;132:1529&#x2013;1532.</Citation><ArticleIdList><ArticleId IdType="pubmed">6607288</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB, Porterfield JS, O&#x2019;Rourke EJ. Enhancement of dengue virus infection in monocytes by flavivirus antisera. Am J Trop Med Hyg. 1980;29:638&#x2013;642. doi: 10.4269/ajtmh.1980.29.638.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.1980.29.638</ArticleId><ArticleId IdType="pubmed">6157332</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejnirattisai W, et al. Cross-reacting antibodies enhance dengue virus infection in humans. Science. 2010;328:745&#x2013;748. doi: 10.1126/science.1185181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1185181</ArticleId><ArticleId IdType="pmc">PMC3837288</ArticleId><ArticleId IdType="pubmed">20448183</ArticleId></ArticleIdList></Reference><Reference><Citation>Beltramello M, et al. The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe. 2010;8:271&#x2013;283. doi: 10.1016/j.chom.2010.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2010.08.007</ArticleId><ArticleId IdType="pmc">PMC3884547</ArticleId><ArticleId IdType="pubmed">20833378</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB, O&#x2019;Rourke EJ. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med. 1977;146:201&#x2013;217. doi: 10.1084/jem.146.1.201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.146.1.201</ArticleId><ArticleId IdType="pmc">PMC2180729</ArticleId><ArticleId IdType="pubmed">406347</ArticleId></ArticleIdList></Reference><Reference><Citation>Villar L, et al. Efficacy of a tetravalent dengue vaccine in children in Latin America. The New England journal of medicine. 2015;372:113&#x2013;123. doi: 10.1056/NEJMoa1411037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1411037</ArticleId><ArticleId IdType="pubmed">25365753</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman AL, Ennis FA. Dengue Vaccine: The Need, the Challenges, and Progress. J Infect Dis. 2016;214:825&#x2013;827. doi: 10.1093/infdis/jiw068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiw068</ArticleId><ArticleId IdType="pmc">PMC4996144</ArticleId><ArticleId IdType="pubmed">26908750</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead, S. B. Dengue Vaccine Efficacy: Not a Zero Sum Game. J Infect Dis, doi:10.1093/infdis/jiw458 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27694632</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X, et al. Contribution of intertwined loop to membrane association revealed by Zika virus full-length NS1 structure. EMBO J. 2016;35:2170&#x2013;2178. doi: 10.15252/embj.201695290.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201695290</ArticleId><ArticleId IdType="pmc">PMC5069551</ArticleId><ArticleId IdType="pubmed">27578809</ArticleId></ArticleIdList></Reference><Reference><Citation>MacLennan CA, et al. Dysregulated humoral immunity to nontyphoidal Salmonella in HIV-infected African adults. Science. 2010;328:508&#x2013;512. doi: 10.1126/science.1180346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1180346</ArticleId><ArticleId IdType="pmc">PMC3772309</ArticleId><ArticleId IdType="pubmed">20413503</ArticleId></ArticleIdList></Reference><Reference><Citation>Puerta-Guardo H, Glasner DR, Harris E. Dengue Virus NS1 Disrupts the Endothelial Glycocalyx, Leading to Hyperpermeability. PLoS Pathog. 2016;12:e1005738. doi: 10.1371/journal.ppat.1005738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005738</ArticleId><ArticleId IdType="pmc">PMC4944995</ArticleId><ArticleId IdType="pubmed">27416066</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen LC, et al. Dengue virus induces thrombomodulin expression in human endothelial cells and monocytes in vitro. J Infect. 2009;58:368&#x2013;374. doi: 10.1016/j.jinf.2009.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2009.02.018</ArticleId><ArticleId IdType="pubmed">19307023</ArticleId></ArticleIdList></Reference><Reference><Citation>Payne AF, Binduga-Gajewska I, Kauffman EB, Kramer LD. Quantitation of flaviviruses by fluorescent focus assay. J Virol Methods. 2006;134:183&#x2013;189. doi: 10.1016/j.jviromet.2006.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2006.01.003</ArticleId><ArticleId IdType="pubmed">16510196</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson PN, et al. Monoclonal antibodies. Molecular pathology: MP. 2000;53:111&#x2013;117. doi: 10.1136/mp.53.3.111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/mp.53.3.111</ArticleId><ArticleId IdType="pmc">PMC1186915</ArticleId><ArticleId IdType="pubmed">10897328</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang XN, Berman AE, Swanson RA, Yenari MA. Digitally quantifying cerebral hemorrhage using Photoshop and Image. J. J Neurosci Methods. 2010;190:240&#x2013;243. doi: 10.1016/j.jneumeth.2010.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneumeth.2010.05.004</ArticleId><ArticleId IdType="pmc">PMC2898728</ArticleId><ArticleId IdType="pubmed">20452374</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>